ATOS Key Stats
|Revenue (Quarterly YoY Growth)||-27.45%|
|EPS Diluted (TTM)||-0.6363|
|EPS Diluted (Quarterly YoY Growth)|
|Net Income (TTM)||-9.733M|
|Gross Profit Margin (Quarterly)||66.14%|
|Profit Margin (Quarterly)||-4572%|
|Dividend Yield (TTM)||0.00%|
|Payout Ratio (TTM) Pro||Go Pro|
- 5 Stocks Poised for Breakouts The Street Dec 9
- Nasdaq stocks posting largest volume increases Dec 6
- Atossa Genetics Announces Two Scientific Presentations at the 2013 San Antonio Breast Cancer Symposium noodls Dec 3
- UPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Atossa Genetics, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 9, 2013 -- ATOS GlobeNewswire Dec 2
- EQUITY ALERT: Rosen Law Firm Reminds Atossa Genetics, Inc. Investors of Important Class Action Deadline -- ATOS GlobeNewswire Nov 27
- DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders of Atossa Genetics, Inc. of Upcoming Deadline Business Wire Nov 25
- UPCOMING DEADLINE: Levi & Korsinsky, LLP Announces Class Action Against Atossa Genetics, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 9, 2013 -- ATOS Business Wire Nov 22
- SHAREHOLDER ALERT: Pomerantz Law Firm has filed a Class Action Against Atossa Genetics, Inc. and Certain Officers - ATOS PR Newswire Nov 22
- ATOSSA GENETICS INC Financials Nov 20
- Unusual 11 Mid-Day Movers 11/19: (IPCI) (SPEX) (EVOK) Higher; (ONVO) (LITB) (CRDS) Lower Street Insider Nov 19
ATOS Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Atossa Genetics is down 36.00% over the last year vs S&P 500 Total Return up 30.68%, BG Medicine down 58.87%, and Bioanalytical Systems up 90.00%.
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Income Statement View Statement
Balance Sheet View Statement
Pro Ratings for ATOS
Pro Strategies Featuring ATOS
Did Atossa Genetics make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.
Atossa Genetics Inc. is a healthcare company involved in the prevention of breast cancer through the commercialization of diagnostic medical devices and laboratory developed tests that can detect precursors to breast cancer.